EcoDrugPlus

Adenosine Receptor A1-Like

Ensembl ID : ENSPNAG00000002422
Gene Symbol: LOC108433661
2 Cross references
114 Possible Orthologues:

Adenosine Receptor A2b-Like

Ensembl ID : ENSPNAG00000017460
Gene Symbol: LOC108428193
3 Cross references
200 Possible Orthologues:

Adenosine Receptor A3-Like

Ensembl ID : ENSPNAG00000012833
Gene Symbol: LOC108433662
2 Cross references
119 Possible Orthologues:

Adhesion Regulating Molecule 1

Ensembl ID : ENSPNAG00000008259
Gene Symbol: ADRM1
3 Cross references
194 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSPNAG00000007173
Gene Symbol: ADRA1B
3 Cross references
196 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSPNAG00000028861
Gene Symbol: ADRA1D
3 Cross references
194 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSPNAG00000017505
Gene Symbol: ADRA2A
3 Cross references
176 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSPNAG00000015848
Gene Symbol: ADRA2C
2 Cross references
157 Possible Orthologues:

Adrenoceptor Beta 1

Ensembl ID : ENSPNAG00000005113
Gene Symbol: ADRB1
1 Cross references
161 Possible Orthologues:

Adrenoceptor Beta 2

Ensembl ID : ENSPNAG00000019838
Gene Symbol: ADRB2
3 Cross references
195 Possible Orthologues:

Adrenoceptor Beta 3

Ensembl ID : ENSPNAG00000017509
Gene Symbol: ADRB3
3 Cross references
144 Possible Orthologues:

Adrenoceptor Beta 3a

Ensembl ID : ENSPNAG00000018201
Gene Symbol: ADRB3A
1 Cross references
196 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).